Office of Technology Management
University Center Tower (UCT)
7000 Fannin Street, Suite 720
Houston, Texas 77030
Phone: (+1) 713-500-3369
Fax: (+1) 713-500-0331
MULTI-FUNCTIONAL LINKING AGENT FOR IMAGING AND THERAPY Imaging technologies are uniquely positioned to enhance how localized and metastatic tumors are treated. In cases where surgery is indicated, a novel class of imaging agents which combine radioactive of fluorescent tags can be used to improve tumor visualization in real-time. When cancer has spread throughout the body, a cytotoxic compound can be combined with radioactive label to develop a “theranostic” method to see and treat disease. Tumor-specificity is critical to the success of these approaches and investigators at T...
Bruxnostic ApplianceBruxism is a significant concern for restorative dentists and orofacial pain practitioners. Consequences of bruxism, if not addressed, can range from minor annoying tooth sensitivity, chronic pain and discomfort, to destruction of dentition and loss of masticatory function. Bruxism is excessive teeth grinding or jaw clenching considered being an oral parafunctional activity. According to relevant literature, its prevalence ranges from 8–31% in the general population according to some studies, while other studies estimated only 10% of the population. Symptoms commonly ...
Background:Every year, more than 1 in 10 babies are born prematurely, before 37 weeks of pregnancy. Complications resulting from preterm birth is the leading cause of death in children under 5 years of age, and the rate of preterm birth has increased steadily in the past decades. Preterm birth due to preterm labor continues to be a challenging concern for the practicing obstetrician. Very few drugs have been proven to be effective in the treatment of preterm labor to improve neonatal outcomes. Unfortunately, tocolytic modalities that have shown to be effective are often limited in ...
NCATS STTR Funding Opportunities Open for Academic Researchers & Entrepreneur
The National Center for Advancing Translational Sciences (NCATS) at the National Institutes of Health invites researchers at academic institutions to apply for Small Business Technology Transfer (STTR) support to commercialize innovations. The next application deadline is Sept. 5, 2018, 5:00 p.m. local time. STTR programs are one of the largest sources of early-stage technology financing in the U.S.
TMCx Open 2018 Medical Device Cohort Application
Deadline: May 14, 2018
TMCx lowers barriers of access to the world's largest medical center, allowing startups to leverage our expansive network of advisors from the 21 Texas Medical Center hospitals and our tailored curriculum to clinically validate and find product-market fit for their solutions.
The TMCx Medical Device 2017 cohort of 19 startups raised $26M and had over 43 engagements with potentials customers in the form of pilots and agreements over the course of our three-month program.